This tag is created dynamically through created issue pages
In comments submitted today, FAH reiterated its full support for CMS’s prospective budget-neutral 340B payment policy to continue to pay Average Sales Price (ASP) minus 22.5 percent for 340B-acquired drugs. “We agree with CMS that […]
Read More… from FAH Comments on CY 2022 Medicare OPPS Proposed Rule
FAH President and CEO Chip Kahn released the following statement after reviewing the FY 2022 Budget Resolution Framework released today by Senate Democrats: “The budget resolution framework released today by Senate Democrats contains several promising […]
Read More… from FAH Leader Reacts to Senate Democrats Budget Framework
